<DOC>
	<DOC>NCT01921452</DOC>
	<brief_summary>This is a Phase 4, single-center, open-label, interventional study, wherein all enrolled subjects will be tested for Thyroid Stimulating Hormone (TSH) by using the quantitative and the qualitative Point-of-Care (POC) TSH test kits and the third generation TSH test kit at the same time.</brief_summary>
	<brief_title>Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit</brief_title>
	<detailed_description />
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>Suspected hypothyroidism subject Willing to comply with the trial protocol Signed informed consent document Menstrual period, bleeding hemorrhoids, hematuria Drinking or taking aspirin within 48 hours Subjects with partially or completely restricted consciousness and behavioral ability, who do not have independent decisionmaking ability. Subjects who are unwilling or unable to complete the trial Subjects who do not sign informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Hypothyroidism</keyword>
	<keyword>Third generation TSH kit</keyword>
	<keyword>Quantitative POC TSH kit</keyword>
	<keyword>Qualitative POC TSH kit</keyword>
</DOC>